Retinoic acid and other retinoids are able to control cellular differentiation and, by so doing, are able to suppress or reverse the transformation of premalignant cells to the malignant state. Therefore, the retinoids have potential value as therapeutic and prophylactic agents for the treatment of cancer if their toxic side effects can be reduced. We propose to synthesize and screen potentially more effective retinoids to develop drugs having an improved therapeutic index (ratio of tumor-inhibitory activity to toxicity). In particular, we propose systematic structure-activity studies of analogs of four active retinoids that we have synthesized--namely, (1) 4-[(E)-2-(4,4-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)-propenyl]benzoic acid, (2) 4-[(E)-2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)-propenyl]benzoi cacid, (3) 4-[(E)-2-(4,4-dimethyl-4,5,6,7-tetrahydro-2-benzo[b]-thienyl)propenyl]benzoi cacid, and (4) 6-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-6-naphthyl)-2-naphthalenecarboxyli cacid--to further determine what regions of the retinoid skeleton enhance tumor-inhibitory activity and reduce toxicity. Compounds will first be tested in three rapid, preliminary screens used to assess retinoid activity: (1) the reversal of keratinization in retinoid-deficient epithelial cells of hamster trachea in organ culture, (2) the inhibition of the induction of ornithine decarboxylase in mouse epidermis treated with a tumor promoter, and (3) the induction of differentiation of F9 murine embryonic carcinoma cells. Active retinoids will then be screened in two in vivo assays to determine (1) their effectiveness in inhibiting papilloma tumor formation in mouse epidermis treated with a carcinogen and a tumor promoter (antipapilloma assay) and (2) their toxicity in the mouse (hypervitaminosis A assay). The therapeutic index will be determined from these two assays. This approach should lead to the design and synthesis of more effective retinoids. In addition, we propose the synthesis of radiolabeled, photoaffinity-labeled retinoids to probe the biochemical mechanism and site of retinoid action.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA032428-07S1
Application #
3170354
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1982-09-01
Project End
1990-04-30
Budget Start
1988-05-01
Budget End
1990-04-30
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Sri International
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Lehmann, J M; Dawson, M I; Hobbs, P D et al. (1991) Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res 51:4804-9
Dawson, M I; Hobbs, P D (1990) Synthetic retinoid acid analogs: handling and characterization. Methods Enzymol 189:15-43
Sani, B P; Wille Jr, J J; Dawson, M I et al. (1990) Biologically active aromatic retinoids bearing azido photoaffinity-labeling groups and their binding to cellular retinoic acid-binding protein. Chem Biol Interact 75:293-304
Dawson, M I; Hobbs, P D; Derdzinski, K A et al. (1989) Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids. J Med Chem 32:1504-17
Dawson, M I; Chao, W R; Helmes, C T (1987) Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation. Cancer Res 47:6210-5
Mehta, R G; Schiff, L J; Moore, S J et al. (1986) Cellular retinoic acid-binding protein and its relationship to the biological activity of four synthetic retinoids in hamster tracheal organ culture. In Vitro Cell Dev Biol 22:164-8
Martin, C A; Dawson, M I; McCormick, A M et al. (1986) Specific, covalent binding of an azidoretinoid to cellular retinoic acid-binding protein. Biochem Biophys Res Commun 135:124-30
Dawson, M I; Hobbs, P D; Chan, R et al. (1985) Conformational restrictions of the retinoid skeleton. Ciba Found Symp 113:6-28
Chao, W R; Helmes, C T; Dawson, M I (1985) Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activities in CD-1 and Sencar mice. Cancer Lett 29:43-8